Regulacje i polityka gospodarcza · 08/11/2023

Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018-2022

The U.S. Department of Health and Human Services has issued a final rule to address a court-ordered remedy for the 340B-Acquired Drug Payment Policy, following the U.S. Supreme Court's decision in American Hospital Association v. Becerra in 2022, affecting Medicare payment rates for drugs acquired under the 340B Program from 2018 to 2022.